Chemotherapie des Dysgerminoms
- 1 April 1987
- journal article
- research article
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 47 (04) , 282-284
- https://doi.org/10.1055/s-2008-1035823
Abstract
Two patients with metastases after primary surgery to remove a dysgerminoma were successfully treated by chemotherapy. One received monotherapy with chlorambucil, the other vinblastine, bleomycin and cisplatin followed by irradiation. Both survived 5 years without evidence of disease. Dysgerminomas are highly sensitive not only to irradiation but also to chemotherapy. It is suggested that in younger women, in order to preserve fertility, chemotherapy should be used after primary conservative surgery, and irradiation only as a third-line remedy.This publication has 6 references indexed in Scilit:
- A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignanciesAmerican Journal of Obstetrics and Gynecology, 1984
- MIXED GERM-CELL TUMORS OF THE OVARY1984
- COMBINATION CHEMOTHERAPY IN THE MANAGEMENT OF OVARIAN GERM-CELL MALIGNANCIES1984
- Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.Journal of Clinical Oncology, 1983
- GERM-CELL MALIGNANCIES OF THE OVARY1979
- Dysgerminoma of the ovary: Radiation therapy for recurrence and metastasesAmerican Journal of Obstetrics and Gynecology, 1976